ADMP Annual Operating Expenses
$23.63 M
-$3.78 M-13.79%
31 December 2022
Summary:
As of January 20, 2025, ADMP annual total operating expenses is $23.63 million, with the most recent change of -$3.78 million (-13.79%) on December 31, 2022. During the last 3 years, it has fallen by -$12.04 million (-33.75%).ADMP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMP Quarterly Operating Expenses
$4.41 M
-$1.68 M-27.62%
30 June 2023
Summary:
As of January 20, 2025, ADMP quarterly total operating expenses is $4.41 million, with the most recent change of -$1.68 million (-27.62%) on June 30, 2023. Over the past year, it has dropped by -$3.12 million (-41.41%).ADMP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMP Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.8% | -41.4% |
| 3 y3 years | -33.8% | -49.5% |
| 5 y5 years | -22.1% | -60.6% |
ADMP Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -47.2% | -69.3% |
Adamis Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $4.41 M(-27.6%) |
| Mar 2023 | - | $6.09 M(+51.9%) |
| Dec 2022 | $23.63 M(-13.8%) | $4.01 M(-10.6%) |
| Sept 2022 | - | $4.49 M(-40.4%) |
| June 2022 | - | $7.53 M(-1.0%) |
| Mar 2022 | - | $7.60 M(+49.3%) |
| Dec 2021 | $27.41 M(-2.6%) | $5.09 M(-45.9%) |
| Sept 2021 | - | $9.41 M(+32.0%) |
| June 2021 | - | $7.13 M(+23.6%) |
| Mar 2021 | - | $5.77 M(-51.5%) |
| Dec 2020 | $28.13 M(-21.1%) | $11.90 M(+140.1%) |
| Sept 2020 | - | $4.96 M(-43.3%) |
| June 2020 | - | $8.74 M(+8.0%) |
| Mar 2020 | - | $8.09 M(+15.9%) |
| Dec 2019 | $35.66 M(-20.3%) | $6.98 M(-19.0%) |
| Sept 2019 | - | $8.62 M(-12.5%) |
| June 2019 | - | $9.85 M(-3.6%) |
| Mar 2019 | - | $10.22 M(-28.9%) |
| Dec 2018 | $44.74 M(+47.4%) | $14.38 M(+37.7%) |
| Sept 2018 | - | $10.44 M(-6.7%) |
| June 2018 | - | $11.20 M(+28.4%) |
| Mar 2018 | - | $8.72 M(-7.5%) |
| Dec 2017 | $30.35 M(+13.1%) | $9.43 M(+34.7%) |
| Sept 2017 | - | $7.00 M(+2.3%) |
| June 2017 | - | $6.84 M(-3.4%) |
| Mar 2017 | - | $7.08 M(+18.7%) |
| Dec 2016 | $26.82 M(+93.7%) | $5.96 M(-12.7%) |
| Sept 2016 | - | $6.83 M(-14.8%) |
| June 2016 | - | $8.01 M(+33.2%) |
| Mar 2016 | - | $6.02 M(+110.2%) |
| Dec 2015 | $13.85 M(+71.0%) | $2.86 M(-13.5%) |
| Sept 2015 | - | $3.31 M(-6.3%) |
| June 2015 | - | $3.53 M(-14.9%) |
| Mar 2015 | - | $4.15 M(+113.7%) |
| Dec 2014 | $8.10 M(+84.3%) | - |
| Sept 2014 | - | $1.94 M(-29.4%) |
| June 2014 | - | $2.75 M(+60.5%) |
| Mar 2014 | $4.40 M(+36.6%) | $1.71 M(+74.1%) |
| Dec 2013 | - | $984.40 K(+2.9%) |
| Sept 2013 | - | $957.00 K(+29.4%) |
| June 2013 | - | $739.80 K(-17.2%) |
| Mar 2013 | $3.22 M(-33.2%) | $893.90 K(+19.5%) |
| Dec 2012 | - | $747.80 K(-12.1%) |
| Sept 2012 | - | $851.10 K(+17.4%) |
| June 2012 | - | $724.70 K(-36.1%) |
| Mar 2012 | $4.82 M(-22.8%) | $1.13 M(+14.6%) |
| Dec 2011 | - | $988.70 K(-33.2%) |
| Sept 2011 | - | $1.48 M(+22.1%) |
| June 2011 | - | $1.21 M(+8.5%) |
| Mar 2011 | $6.24 M(+55.8%) | $1.12 M(-63.0%) |
| Dec 2010 | - | $3.02 M(+171.6%) |
| Sept 2010 | - | $1.11 M(+12.5%) |
| June 2010 | - | $989.10 K(-47.1%) |
| Mar 2010 | $4.01 M | $1.87 M(+146.7%) |
| Dec 2009 | - | $757.40 K(+18.7%) |
| Sept 2009 | - | $638.20 K(-14.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $742.60 K(+132.8%) |
| Mar 2009 | - | $319.00 K(+23.1%) |
| Dec 2008 | $1.32 M(-27.4%) | $259.10 K(-1.1%) |
| Sept 2008 | - | $262.00 K(-21.8%) |
| June 2008 | - | $335.00 K(-28.0%) |
| Mar 2008 | - | $465.00 K(+2.5%) |
| Dec 2007 | $1.82 M(-74.3%) | $453.60 K(+11.7%) |
| Sept 2007 | - | $406.00 K(-7.9%) |
| June 2007 | - | $441.00 K(-15.4%) |
| Mar 2007 | - | $521.00 K(+1123.0%) |
| Dec 2006 | $7.09 M(-59.0%) | $42.60 K(-97.3%) |
| Sept 2006 | - | $1.57 M(-30.9%) |
| June 2006 | - | $2.27 M(-29.2%) |
| Mar 2006 | - | $3.21 M(-13.0%) |
| Dec 2005 | $17.31 M(+8.4%) | $3.69 M(-12.5%) |
| Sept 2005 | - | $4.22 M(+58.7%) |
| June 2005 | - | $2.66 M(-60.9%) |
| Mar 2005 | - | $6.79 M(+21.9%) |
| Dec 2004 | $15.97 M(+4.2%) | $5.57 M(+53.9%) |
| Sept 2004 | - | $3.62 M(+12.8%) |
| June 2004 | - | $3.21 M(-9.9%) |
| Mar 2004 | - | $3.56 M(-11.6%) |
| Dec 2003 | $15.33 M(-12.4%) | $4.03 M(+27.2%) |
| Sept 2003 | - | $3.17 M(-36.9%) |
| June 2003 | - | $5.03 M(+67.9%) |
| Mar 2003 | - | $2.99 M(-38.6%) |
| Dec 2002 | $17.49 M(-3.6%) | $4.87 M(+157.9%) |
| Sept 2002 | - | $1.89 M(-67.9%) |
| June 2002 | - | $5.89 M(+21.7%) |
| Mar 2002 | - | $4.84 M(-5.4%) |
| Dec 2001 | $18.14 M(+32.3%) | $5.11 M(+16.6%) |
| Sept 2001 | - | $4.38 M(-0.3%) |
| June 2001 | - | $4.40 M(+3.7%) |
| Mar 2001 | - | $4.24 M(-12.9%) |
| Dec 2000 | $13.71 M(+24.6%) | $4.87 M(+40.7%) |
| Sept 2000 | - | $3.46 M(+16.8%) |
| June 2000 | - | $2.96 M(+23.2%) |
| Mar 2000 | - | $2.41 M(-22.4%) |
| Dec 1999 | $11.00 M(+19.6%) | $3.10 M(+40.9%) |
| Sept 1999 | - | $2.20 M(-17.0%) |
| June 1999 | - | $2.65 M(-11.6%) |
| Mar 1999 | - | $3.00 M(+25.0%) |
| Dec 1998 | $9.20 M(+70.4%) | $2.40 M(-7.7%) |
| Sept 1998 | - | $2.60 M(0.0%) |
| June 1998 | - | $2.60 M(+52.9%) |
| Mar 1998 | - | $1.70 M(-10.5%) |
| Dec 1997 | $5.40 M(+25.6%) | $1.90 M(+58.3%) |
| Sept 1997 | - | $1.20 M(0.0%) |
| June 1997 | - | $1.20 M(+9.1%) |
| Mar 1997 | - | $1.10 M(-15.4%) |
| Dec 1996 | $4.30 M(+38.7%) | $1.30 M(+18.2%) |
| Sept 1996 | - | $1.10 M(+10.0%) |
| June 1996 | - | $1.00 M(+11.1%) |
| Mar 1996 | - | $900.00 K(-57.1%) |
| Dec 1995 | $3.10 M | $2.10 M(+425.0%) |
| Sept 1995 | - | $400.00 K(+33.3%) |
| June 1995 | - | $300.00 K |
FAQ
- What is Adamis Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals annual operating expenses year-on-year change?
- What is Adamis Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals quarterly operating expenses year-on-year change?
What is Adamis Pharmaceuticals annual total operating expenses?
The current annual operating expenses of ADMP is $23.63 M
What is the all time high annual operating expenses for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high annual total operating expenses is $44.74 M
What is Adamis Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, ADMP annual total operating expenses has changed by -$3.78 M (-13.79%)
What is Adamis Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of ADMP is $4.41 M
What is the all time high quarterly operating expenses for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high quarterly total operating expenses is $14.38 M
What is Adamis Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, ADMP quarterly total operating expenses has changed by -$3.12 M (-41.41%)